Workflow
Tevogen Bio(TVGN)
icon
搜索文档
Tevogen Bio(TVGN) - 2021 Q3 - Quarterly Report
2021-12-18 06:17
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the quarterly period ended September 30, 2021 FORM 10-Q ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) For the transition period from to ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Registrant's telephone number, including area code) Commission File No. 001-41002 SEMPER PARATUS ACQUISITION CORPORATION (Exact name of ...